Cargando…
Upregulated lncRNA CASC2 May Inhibit Malignant Melanoma Development Through Regulating miR-18a-5p/RUNX1
This study aimed to investigate the effect and underlying mechanism of lncRNA CASC2 in malignant melanoma (MM). Expression of CASC2 in MM tissues and cells was detected. A375 cells were transfected with pc-CASC2, si-CASC2, miR-18a-5p inhibitor, or corresponding controls, and then cell proliferation,...
Autores principales: | Zhang, Yankun, Qian, Wei, Feng, Feng, Cao, Qian, Li, Yanqi, Hou, Ying, Zhang, Luyang, Fan, Jufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cognizant Communication Corporation
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7848445/ https://www.ncbi.nlm.nih.gov/pubmed/29422114 http://dx.doi.org/10.3727/096504018X15178740729367 |
Ejemplares similares
-
LncRNA CASC 2 is upregulated in aphthous stomatitis and predicts the recurrence
por: Lu, Jiaping, et al.
Publicado: (2020) -
LncRNA CASC11 is upregulated in postmenopausal osteoporosis and is correlated with TNF-α
por: Yu, Haotao, et al.
Publicado: (2019) -
The role of lncRNA CASC2 on prognosis of malignant tumors: a
meta-analysis and bioinformatics
por: Yu, Lingling, et al.
Publicado: (2018) -
The lncRNA CASC15 regulates SOX4 expression in RUNX1-rearranged acute leukemia
por: Fernando, Thilini R., et al.
Publicado: (2017) -
Significance of LncRNA CASC8 genetic polymorphisms on the tuberculosis susceptibility in Chinese population
por: Liu, Guoye, et al.
Publicado: (2020)